Latest news with #KKStock
New York Post
2 days ago
- Health
- New York Post
Ozempic penis: Male users reveal shocking change to their genitalia after injecting weight-loss shot
It's the miracle drug that promises to shrink your size — except where it matters. Male Ozempic users say their penises have gotten bigger since they started injecting the weight-loss shot, with dozens of well-endowed fellas flocking to online forums to fawn over their expanded members. 'I recently measured myself down there and noticed I gained about one inch,' an anonymous user recently claimed on a Reddit thread. Advertisement 'Now I think people will say it was because of the fat loss. However at the time I measured myself before (4 years ago), I was thinner,' the man claimed. 'I also bone pressed during measurement before and also this time. Has anyone else noticed this change in themselves?' 3 Male Ozempic users say their penises have gotten bigger since they started injecting the weight-loss shot, with dozens of well-endowed fellas flocking to online forums to fawn over their expanded members. Shutterstock / Andrey_Popov 'Yes,' another happy Redditor responded. 'I gained 1.5 inches in length. No joke. Like you I obviously know how long I was before I got very fat. Then after about seven months on Tirzepatide in my case I gained 1.5 inches in length. Definitely not all from weight loss.' Advertisement 'I noticed that happen to me as well,' a third man remarked. 'Yeah, wife has definitely noticed a difference, was 278lbs down to under 200 lbs,' an additional commenter claimed. Meanwhile, other men also claimed that they had noticed a size difference after taking Ozempic, but put it down to better blood flow and reduced fat around the pubic area. Advertisement Another Redditor responded saying the size difference was likely due to different external conditions during the before and after measurements. 'I feel like nobody is really reading what you are writing, that they blame the weight loss while you measured the first time when you were actually lighter,' the explained. 'Ozempic does not enlarge your penis, but an erect penis may change size considerably depending on time of day, temperature, and factors other than sexual arousal. So it's probably just simply that.' 3 Some men also admitted that they had noticed a size difference after taking Ozempic, but put it down to better blood flow and reduced fat around the pubic area. myskin – Advertisement 3 Since it became widely available across America in 2024, users have reported an array of unexpected side effects. K KStock – The phenonemon — dubbed 'Ozempic penis' or 'Ozemd**k' — is just the latest in a series of side effects users of the weight-loss drugs have allegedly experencied. 'Ozempic mouth' is another recently reported side effect, marked by pronounced folds at the corners of the mouth, noticeable wrinkles on the lips, and sagging skin along the lip contours and chin area Those alarmed by their changed appearance are now turning to cosmetic treatments – such as dermal fillers – to restore lost volume around the mouth area.
Yahoo
16-05-2025
- Health
- Yahoo
Novo Nordisk's Ozempic Weight Loss Jabs Could Boost UK Economy By $6 Billion, Study Finds
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Making weight loss injections available to all eligible individuals in the U.K. could yield an economic boost of 4.5 billion pounds (around $5.99 billion) annually, according to new research presented at the European Congress on Obesity in Málaga, Spain. The findings highlight the broader societal and productivity benefits of Novo Nordisk A/S' (NYSE:NVO) semaglutide, a drug known by brand names such as Wegovy and Ozempic. Globally, obesity is projected to affect 3.8 billion adults and nearly 750 million children and adolescents by 2050. Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — In the U.K., 26.5% of adults are currently obese, and 4.6 million people live with type 2 diabetes. These conditions cost the U.K. an estimated 100 billion pounds annually in healthcare and related expenses, according to the Guardian report. The study examined data from 2,660 participants in U.K. clinical trials who were living with obesity and/or type 2 diabetes. Researchers found that those taking semaglutide could work five additional days per year and contribute 12 extra days of unpaid labor, such as volunteering or childcare. This increase in productivity translated to an average annual 'net production value' of 1,127 pounds per person. Applied nationally, the researchers estimated potential productivity gains of 4.31 billion pounds from treating individuals with severe obesity and 200 million pounds from treating those with type 2 NHS guidelines recommend semaglutide for patients with a BMI of 35 or higher and at least one weight-related condition. However, some experts cautioned against widespread access due to high drug costs. The U.K. Health Secretary Wes Streeting acknowledged the findings, calling the drugs 'colossal' tools in the fight against obesity and a potential means to reintegrate unemployed Britons into the workforce. He said the government would carefully assess the research. Semaglutide and liraglutide may also have implications beyond weight loss. Citing another study presented at the Málaga conference, the Guardian report on Friday highlighted that overweight adults taking the drugs cut their alcohol consumption by nearly two-thirds in just four months. The study tracked 262 individuals in Ireland and Saudi Arabia and reported a drop in weekly alcohol intake from 11.3 to 4.3 units. Among regular drinkers, consumption fell from 23.2 to 7.8 units—an effect greater than that seen with nalmefene, a drug currently prescribed in Europe for alcohol use disorder. Read Next: Hasbro, MGM, and Skechers trust this AI marketing firm — Invest at $0.60/share before it's too late. Invest Where It Hurts — And Help Millions Heal: Invest in Cytonics and help disrupt a $390B Big Pharma stronghold. Photo by KK Stock via Shutterstock Send To MSN: Send to MSN This article Novo Nordisk's Ozempic Weight Loss Jabs Could Boost UK Economy By $6 Billion, Study Finds originally appeared on
